Use of Lhasa Limited Products for the In Silico Prediction of Drug Toxicity

Methods Mol Biol. 2022:2425:435-478. doi: 10.1007/978-1-0716-1960-5_17.

Abstract

Lhasa Limited have had a role in the in silico prediction of drug and other chemical toxicity for over 30 years. This role has always been multifaceted, both as a provider of predictive software such as Derek Nexus, and as an honest broker for the sharing of proprietary chemical and toxicity data. A changing regulatory environment and the drive for the Replacement, Reduction and Refinement (the 3Rs) of animal testing have led both to increased acceptance of in silico predictions and a desire for the sharing of data to reduce duplicate testing. The combination of these factors has led to Lhasa Limited providing a suite of products and coordinating numerous data-sharing consortia that do indeed facilitate a significant reduction in the testing burden that companies would otherwise be laboring under. Many of these products and consortia can be organized into workflows for specific regulatory use cases, and it is these that will be used to frame the narrative in this chapter.

Keywords: Drug toxicity; Genotoxicity; In silico models; Lhasa Limited products; Toxicophore.

MeSH terms

  • Animals
  • Computer Simulation
  • Drug-Related Side Effects and Adverse Reactions*
  • Software*